ERC FUNDED PROJECTS

2D-PnictoChem aims at exploring the Chemistry of a novel class of graphene-like 2D layered elemental materials of group 15, the pnictogens: P, As, Sb, and Bi. In the last few years, these materials have taken the field of Materials Science by storm since they can outperform and/or complement graphene properties. Their strongly layer-dependent unique properties range from semiconducting to metallic, including high carrier mobilities, tunable bandgaps, strong spin-orbit coupling or transparency. However, the Chemistry of pnictogens is still in its infancy, remaining largely unexplored. This is the niche that 2D-PnictoChem aims to fill. By mastering the interface chemistry, we will develop the assembly of 2Dpnictogens in complex hybrid heterostructures for the first time. Success will rely on a cross-disciplinary approach combining both Inorganic- and Organic Chemistry with Solid-state Physics, including: 1) Synthetizing and exfoliating high quality ultra-thin layer pnictogens, providing reliable access down to the monolayer limit. 2) Achieving their chemical functionalization via both non-covalent and covalent approaches in order to tailor at will their properties, decipher reactivity patterns and enable controlled doping avenues. 3) Developing hybrid architectures through a precise chemical control of the interface, in order to promote unprecedented access to novel heterostructures. 4) Exploring novel applications concepts achieving outstanding performances. These are all priorities in the European Union agenda aimed at securing an affordable, clean energy future by developing more efficient hybrid systems for batteries, electronic devices or applications in catalysis. The opportunity is unique to reduce Europe’s dependence on external technology and the PI’s background is ideally suited to tackle these objectives, counting as well on a multidisciplinary team of international collaborators.

1 499 419 €

Start date: 2018-11-01, End date: 2023-10-31

Ubiquitous in nature, light-matter interactions are of fundamental importance in science and all optical technologies. Understanding and controlling them has been a long-pursued objective in modern physics. However, so far, related experiments have relied on traditional optical schemes where, owing to the classical diffraction limit, control of optical fields to length scales below the wavelength of light is prevented. Importantly, this limitation impedes to exploit the extraordinary fundamental and scaling potentials of nanoscience and nanotechnology. A solution to concentrate optical fields into sub-diffracting volumes is the excitation of surface polaritons –coupled excitations of photons and mobile/bound charges in metals/polar materials (plasmons/phonons)-. However, their initial promises have been hindered by either strong optical losses or lack of electrical control in metals, and difficulties to fabricate high optical quality nanostructures in polar materials. With the advent of two-dimensional (2D) materials and their extraordinary optical properties, during the last 2-3 years the visualization of both low-loss and electrically tunable (active) plasmons in graphene and high optical quality phonons in monolayer and multilayer h-BN nanostructures have been demonstrated in the mid-infrared spectral range, thus introducing a very encouraging arena for scientifically ground-breaking discoveries in nano-optics. Inspired by these extraordinary prospects, this ERC project aims to make use of our knowledge and unique expertise in 2D nanoplasmonics, and the recent advances in nanophononics, to establish a technological platform that, including coherent sources, waveguides, routers, and efficient detectors, permits an unprecedented active control and manipulation (at room temperature) of light and light-matter interactions on the nanoscale, thus laying experimentally the foundations of a 2D nano-optics field.

1 459 219 €

Start date: 2017-01-01, End date: 2021-12-31

Wave-particle interactions are ubiquitous in nature and play a fundamental role in astrophysical and fusion plasmas. In solar plasmas, magnetohydrodynamic (MHD) fluctuations are thought to be responsible for the heating of the solar corona and the generation of the solar wind. In magnetically confined fusion (MCF) devices, enhanced particle transport induced by MHD fluctuations can deteriorate the plasma confinement, and also endanger the device integrity. MCF devices are an ideal testbed to verify current models and develop mitigation / protection techniques. The proposed project paves the way for providing active control techniques to tame the MHD induced particle transport in a fusion plasma. A solid understanding of the interaction between energetic particles and MHD instabilities in the presence of electric fields and plasma currents is required to develop such techniques. I will pursue this goal through innovative diagnosis techniques with unprecedented spatio-temporal resolution. Combined with state-of-the-art hybrid MHD codes, a deep insight into the underlying physics mechanism will be gained. The outcome of this research project will have a major impact for next-step MCF devices as I will provide ground-breaking control techniques for mitigating MHD induced particle transport in magnetized plasmas. The project consists of 3 research lines which follow a bottom-up approach: (1) Cutting-edge instrumentation, aiming at the new generation of energetic particle and edge current diagnostics. (2) Unravel the dynamics of energetic particles, electric fields, edge currents and MHD fluctuations. (3) From lab to space weather: The developed models will revolutionize our understanding of the observed particle acceleration and transport in the solar corona. Based on this approach, the project represents a gateway between the fusion, astrophysics and space communities opening new avenues for a common basic understanding.

1 512 250 €

Start date: 2019-05-01, End date: 2024-04-30

The clinical success of anticancer and antiviral vaccines often requires the use of an adjuvant, a substance that helps stimulate the body’s immune response to the vaccine, making it work better. However, few adjuvants are sufficiently potent and non-toxic for clinical use; moreover, it is not really known how they work. Current vaccine approaches based on weak carbohydrate and glycopeptide antigens are not being particularly effective to induce the human immune system to mount an effective fight against cancer. Despite intensive research and several clinical trials, no such carbohydrate-based antitumor vaccine has yet been approved for public use. In this context, the proposed project has a double, ultimate goal based on applying chemistry to address the above clear gaps in the adjuvant-vaccine field. First, I will develop new improved adjuvants and novel chemical strategies towards more effective, self-adjuvanting synthetic vaccines. Second, I will probe deeply into the molecular mechanisms of the synthetic constructs by combining extensive immunological evaluations with molecular target identification and detailed conformational studies. Thus, the singularity of this multidisciplinary proposal stems from the integration of its main objectives and approaches connecting chemical synthesis and chemical/structural biology with cellular and molecular immunology. This ground-breaking project at the chemistry-biology frontier will allow me to establish my own independent research group and explore key unresolved mechanistic questions in the adjuvant/vaccine arena with extraordinary chemical precision. Therefore, with this transformative and timely research program I aim to (a) develop novel synthetic antitumor and antiviral vaccines with improved properties and efficacy for their prospective translation into the clinic and (b) gain new critical insights into the molecular basis and three-dimensional structure underlying the biological activity of these constructs.

1 499 219 €

Start date: 2017-03-01, End date: 2022-02-28